Document is current

Any future updates will be listed below

A phase I study of adjuvant intensity-modulated radiotherapy with concurrent paclitaxel and cisplatin for cervical cancer patients with high risk factors

Crossref DOI link: https://doi.org/10.1007/s12032-015-0689-5

Published Online: 2015-10-03

Published Print: 2015-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark